.gif)
The UBM India Pharma Awards 2015 held on 30th November, 2015 in, Mumbai, celebrated excellence and recognized contribution of Indian Pharmaceutical Companies. The 3rd Edition of Annual India Pharma Awards in association with TAKE solutions provided an opportunity for the companies to showcase their innovations and accomplishments in the sector.
The U.S. Food and Drug Administration approved Vistogard (uridine triacetate) for the emergency treatment of adults and children who receive an overdose of the cancer treatment fluorouracil or capecitabine, or who develop certain severe or life-threatening toxicities within four days of receiving these cancer treatments.
The U.S. Food and Drug Administration approved Alecensa (alectinib) to treat people with advanced (metastatic) ALK-positive non-small cell lung cancer (NSCLC) whose disease has worsened after, or who could not tolerate treatment with, another therapy called Xalkori (crizotinib).
Sun Pharma's manufacturing consolidation in the US, one of its wholly owned subsidiaries has entered into an agreement with Nostrum Laboratories Inc. (Nostrum) for the divestment of the Bryan (Ohio) unit in the US.
Do Not Forget to Verify
(Click on Subscription link in your inbox)
--------
Also Join: 
.png)
